How many institutions held AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share in Q3 2024?

1 institutional investor reported AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share for Q3 2024. Use the holders table for investor-level position and value details.

Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB)

Q: What does CUSIP 005111109 represent in this 13F holders report?

CUSIP 005111109 is the security identifier for AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 005111109

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 60,359,615
Total 13F shares: 3,000
Share change: -3,400
Total reported value: $252
Price per share: $0.08
Number of holders: 1
Value change: -$286
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 005111109?
CUSIP 005111109 identifies AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2024
Previous quarter: Q2 2024

Recent filing periods for CUSIP 005111109:

Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023

Top shareholders of AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	3/4/5	Director, 10%+ Owner	— class O/S missing	1,677,361	$2,616,683	—	19 Jul 2021	3/4/5
Shahzad Malik	3/4/5	Director	— mixed-class rows	1,562,757 mixed-class rows	$2,426,946	—	17 Jun 2021	3/4/5
James F. Hinrichs.	3/4/5	Director	— mixed-class rows	95,910 mixed-class rows	$119,043	—	16 Jun 2022	3/4/5
R. Scott Huennekens	3/4/5	Director	— class O/S missing	529,349	$100,047	—	15 Jun 2023	3/4/5
Vincent J. Burgess	3/4/5	Chief Executive Officer, Director	— class O/S missing	61,469	$95,892	—	01 Apr 2022	3/4/5
Steven McQuillan	3/4/5	SVP, Clinical Affairs & QA	— class O/S missing	45,844	$71,517	—	01 Apr 2022	3/4/5
David Roman	3/4/5	President & CEO	— class O/S missing	332,134	$62,773	—	07 Jan 2024	3/4/5
Tom Sohn	3/4/5	SVP, Gen. Counsel & Secretary	— class O/S missing	105,009	$18,167	—	06 Feb 2024	3/4/5
Daniella Cramp	3/4/5	Director	— mixed-class rows	31,223 mixed-class rows	$18,132	—	16 Jun 2022	3/4/5
Charlie Piscitello	3/4/5	SVP, Chief People Officer	— class O/S missing	85,683	$16,194	—	01 Apr 2023	3/4/5
Takeo Mukai	3/4/5	CFO	— class O/S missing	72,874	$15,304	—	01 Mar 2024	3/4/5
Kevin Mathews	3/4/5	SVP, Commercial	— class O/S missing	61,106	$11,549	—	07 Jan 2024	3/4/5
John F. Sheridan	3/4/5	Director	— class O/S missing	24,347	$4,602	—	15 Jun 2023	3/4/5
Jason K. Garland	3/4/5	Director	— class O/S missing	22,400	$4,234	—	15 Jun 2023	3/4/5
Niamh Louise Pellegrini	3/4/5	Director	— class O/S missing	20,972	$3,964	—	15 Jun 2023	3/4/5
Andrew ElBardissi	3/4/5	Director	— class O/S missing	20,822	$3,935	—	15 Jun 2023	3/4/5
David P. Bonita	3/4/5	Director	— class O/S missing	20,822	$3,935	—	15 Jun 2023	3/4/5
Shaden Marzouk	3/4/5	Director	— class O/S missing	20,822	$3,935	—	15 Jun 2023	3/4/5
S.A. Mason LLC	13F	Company	0.01%	6,400	$227	—	30 Jun 2024	13F

Institutional Holders of Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) as of Q3 2024

As of 30 Sep 2024, Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 3,000 shares. The largest 1 holders included S.A. Mason LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q3 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 Value $	Q3 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.